Redefining Pharma Excellence at the 5th Annual Pharma GMP and Quality Management 2025

The pharmaceutical industry is undergoing rapid transformation, with an increasing focus on quality, compliance, and innovation in manufacturing processes. In this context, Eminence Business Media has announced 5th Annual Pharma GMP and Quality Management 2025, scheduled for April 24th–25th, 2025, in the vibrant city Mumbai. The conference is co-located with Pharma Quality Excellence Awards 2025. 

This conference aims to unite industry leaders, regulatory experts, and quality professionals to discuss and share best practices related to Good Manufacturing Practices (GMP) and highlight how technology is reshaping quality assurance and compliance in pharma with the event theme focusing on ‘Tech-Driven Quality: Redefining Pharma Excellence.” 

With the objective of enhancing quality standards across the sector, the conference will delve into critical topics such as global GMP regulations, risk management, and the integration of Quality by Design (QbD) principles. Attendees will explore the latest technological advancements, including automation and artificial intelligence, and their impact on quality control and continuous manufacturing with step-by-step approach to adoption of innovation in the right way. 

Furthermore, the event will emphasize the importance of training and development in cultivating a skilled workforce that upholds high-quality standards. By fostering collaboration and knowledge sharing, the 5th Annual Pharma GMP and Quality Management 2025 aims to address the challenges faced by the pharmaceutical industry while promoting a culture of quality and compliance. This gathering not only provides a platform for insightful discussions and practical workshops but also offers invaluable networking opportunities, enabling participants to build relationships that can lead to innovative partnerships and initiatives. 

As we look to the future, this conference stands as a pivotal opportunity for professionals committed to advancing excellence in pharmaceutical manufacturing and ensuring the safety and efficacy of products that ultimately benefit patients worldwide. Eminence invites you to join them to redefine the future of pharma and register today on www.gxpqualitymanagement.com and take advantage of early bird discounts to take advantage of the limited seating program.

Theme: P.R.I.D.E. - Performance, Reliability, Innovation, Development, and EHS

After a successful edition of the maiden award ceremony in 2024, Eminence is thrilled to announce the Pharma Quality Excellence Awards 2025, taking place on April 25th, 2025, in conjunction with the 5th Annual Pharma GMP and Quality Management 2025 conference in Mumbai. This award ceremony is dedicated to recognizing the outstanding contributions of quality teams within the pharmaceutical industry. The theme for this year’s awards is P.R.I.D.E.; which stands for Performance, Reliability, Innovation, Development, and EHS (Environmental, Health, and Safety).

The Pharma Quality Excellence Awards aim to celebrate teams that exemplify excellence in these five critical areas, showcasing their commitment to maintaining high-quality standards and advancing industry practices. By honouring organizations that prioritize performance and reliability, the ceremony highlights the importance of consistent quality in pharmaceutical manufacturing. The awards will also spotlight innovative initiatives that have led to significant advancements in quality management, as well as the professional development efforts that empower teams to thrive in an ever-evolving landscape. 

Additionally, the awards will recognize those who prioritize EHS practices, reflecting a commitment to sustainability and the well-being of employees and the community. The event promises to foster a spirit of camaraderie and collaboration, bringing together industry leaders and quality professionals to share their experiences and insights. 

If you have reached there, send in your nominations today to celebrate the achievements of the pharmaceutical quality community and to inspire ongoing excellence and innovation. The Pharma Quality Excellence Awards 2025 will not only honour the hard work and dedication of quality teams but also serve as a platform for knowledge exchange and networking among peers. Nominate today at www.thepharmaawards.com and together, let’s recognize the contributions and inspire a future of excellence in pharma quality today.

Cosmo Specialty Chemicals introduces eco-friendly barrier coating solutions for sustainable packaging

Cosmo Specialty Chemicals, a 100% subsidiary of Cosmo First and a one-stop solution for a range of Adhesives, Masterbatches, and Coating Chemicals, has launched its innovative range of Oil and Grease Resistant (OGR) barrier coatings. These advanced solutions offer sustainable alternatives to traditional polyethylene coatings, addressing growing environmental concerns while maintaining superior performance.

Globally, various governments have implemented phasing out traditional polyethylene coatings focusing on sustainable packaging solutions. Cosmo Specialty Chemicals is moving in this direction by launching two distinct grade OGR coatings - OGR 145B and OGR 145S - designed to meet diverse packaging requirements across industries. These water-based formulations are a sought-after solution for the packaging industry in its efforts toward green manufacturing.

“Our new range of OGR barrier coatings reflects Cosmo Specialty Chemicals' commitment to innovation and sustainability,” said Mr Raj Sharma, Business Head of Cosmo Specialty Chemicals. “By developing eco-friendly alternatives that maintain high-performance standards, we are addressing the current market demands and anticipated future needs. These solutions deliver exceptional barrier properties while supporting our customers' environmental goals and regulatory compliance requirements.”

The OGR 145B, a non-heat sealable barrier coating, offers excellent oil and grease resistance for food packaging applications. Its unique formulation provides superior water and oil resistance properties, versatile coating application compatibility, anti-blocking properties, zero VOC emissions and is FDA compliance for direct food contact.

Complementing this, the OGR 145S variant introduces heat-sealing capabilities, specifically engineered for paper cup manufacturing. This coating delivers enhanced heat-seal properties for paper-to-paper bonding, excellent resistance against water, moisture, oil, and grease, flexible application options including gravure, flexo, and air knife coating and food-grade compliance for safety.

Both products undergo rigorous testing through KIT and Cobb Index measurements, ensuring optimal performance in grease resistance and water absorbency. These scientifically validated parameters guarantee consistent quality and reliable barrier protection across various applications.

Sharpness, Brilliance, and Reliable Performance - hubergroup launches Cold Foil Silver and Cold Foil Gold adhesives for FCM applications

hubergroup is thrilled to introduce its latest innovations: Cold Foil Silver and Cold Foil Gold adhesives, specially designed for Food Contact Material (FCM) applications. Tailored for packaging manufacturers in the confectionery, chocolate, tobacco, and hygiene sectors, these cutting-edge products meet the highest standards for visual quality, safety, and efficiency in print production.

Unmatched Brilliance and Precision
The new Cold Foil Silver and Cold Foil Gold adhesives are powered by hubergroup's advanced UV-curing cold foil adhesives, NewV lac MGA to provide sharp definition and dazzling brilliance. With rapid curing speeds and top-tier press performance, these cold foil solutions offer brands the opportunity to achieve high-impact metallic effects with precision. Developed to maximize production efficiency, they also reduce material consumption by minimizing initial print waste, supporting a more cost-effective and eco-conscious production process.

Uncompromising Safety and Regulatory Compliance
Developed in collaboration with leading foil manufacturers, these products undergo stringent testing, ensuring they are available for immediate use worldwide. In addition to their excellent press performance, Cold Foil Silver and Cold Foil Gold adhesives uphold the highest product safety standards. Both products are compliant with key regulatory standards, including the EuPIA Suitability List of Photoinitiators and Photosynergists for Food Contact Materials, EuPIA Guideline for Printing Inks applied to Food Contact Materials and the Good Manufacturing Practices (GMP) for FCM Printing Inks. They are formulated according to the Swiss Ordinance on Materials and Articles in Contact with Food (SR 817.023.21) allowing the printed article being compliant to the Framework Regulation (EC) No. 1935/2004, along with the Plastics Regulation (EU) No. 10/2011.

Efficiency and Sustainability Combined
Beyond their striking visual effects and safety credentials, Cold Foil Silver and Cold Foil Gold adhesives also offer reduced costs and lower waste through minimized make-ready materials and initial run losses. These products are part of hubergroup’s commitment to sustainable production, empowering companies to reduce their environmental impact without sacrificing quality.

“With Cold Foil Silver and Gold adhesives, we are setting new standards in brilliance: our customers receive a premium printing solution that combines high safety and striking effects – ideal for a demanding market,” says Patrick Hübel, Director of Global Product and Color Management at hubergroup.

With these latest innovations, hubergroup reaffirms its leadership in the printing industry, underscoring a commitment to safety, sustainability, and efficiency. Cold Foil Silver and Cold Foil Gold adhesives are now available globally, offering print shops a solution that effortlessly merges technical excellence with environmental responsibility.

6th Annual Pharma Manufacturing & Automation Convention 2024

The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day 6th Annual Pharma Manufacturing and Automation Convention 2024 program focused on embracing automation and innovation; leaders, experts, and professionals are set to explore the latest trends, challenges, and advancements shaping the future of pharma. Eminence Business Media has scheduled the conference for October 17th – 18th, 2024 at Hotel Westin Mindspace, Hyderabad.

Day one of the conference will delve into cutting-edge topics such as Industry 4.0 implementation strategies, advanced automation technologies, data integrity in manufacturing processes, and compliance requirements. Discussions will centre around harnessing the power of robotics, artificial intelligence, and lean manufacturing principles to optimize production processes and enhance operational excellence.

Day two will pivot towards practical insights on IT infrastructure integration, regulatory compliance considerations, and predictive maintenance strategies for automated systems. Case studies and best practices in robotics and AI applications will be shared, emphasizing the importance of seamless integration and quality assurance in pharmaceutical manufacturing.

Attendees can expect a deep dive into the regulatory landscape governing automated manufacturing, ensuring that compliance and quality standards are met across API manufacturing and formulation companies. This comprehensive agenda aims to equip industry professionals with the knowledge and tools needed to thrive in the era of digital transformation and innovation within the pharmaceutical manufacturing sector. 

 

Why to Attend:

Expert Speakers: Engage with a line-up of distinguished speakers, including industry veterans, innovators, and experts who have spearheaded transformative initiatives. Their first-hand experiences and knowledge will provide invaluable guidance for attendees.

Interactive Q&A Sessions: Participate in interactive Q&A sessions with speakers and panellists. This is a unique opportunity to directly engage with thought leaders, ask questions, and gain personalized insights that address your specific challenges and concerns.

Real-World Case Studies: Dive into real-world case studies that showcase successful implementations of automation in pharmaceutical manufacturing. Learn from practical examples that demonstrate how automation has improved efficiency, quality, and compliance.

Networking Opportunities: Connect with professionals, peers, and potential collaborators from across the pharmaceutical and automation industries. Forge meaningful relationships, exchange ideas, and explore potential partnerships that could drive your projects forward.

Future Insights: Gain a glimpse into the future of pharmaceutical manufacturing. Delve into discussions about emerging technologies, AI-driven processes, and their potential impact on the industry's evolution.

Networking Reception: Join us for a lively networking reception where you can relax, unwind, and continue conversations in a casual setting. Forge connections, exchange business cards, and build relationships that extend beyond the conference.

Who will Attend: From CXOs, Managing Directors, Presidents, and Vice Presidents to Sr. GMs, GMs and mid-level management, everyone can reap the benefits of this platform to learn and network with industry peers stalwarts.

•           Manufacturing

•           Production

•           Automation

•           Tech Transfer

•           Quality

•           IT

•           Academia

Pharma Manufacturing & Automation Excellence Awards 2024: Honoring the Visionaries Behind Pharma's Transformational Growth

Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth, as companies embrace digital technologies for greater efficiency and innovation.

Fueled by the global demand for innovative solutions, enhanced production capabilities, and the rise of automation technologies, the industry has seen remarkable advancements. Automation in pharma has particularly surged, streamlining processes and driving unparalleled efficiency, compliance, and productivity.

Amidst this transformative growth, the Pharma Manufacturing & Automation Excellence Awards 2024 is set to honor the visionaries and organizations who have propelled the industry forward. Scheduled for October 18th, 2024, at the prestigious Hotel Westin Mindspace, Hyderabad, this event serves as a tribute to the brilliance and innovation shaping the future of pharma manufacturing.

This year’s awards are centered around the theme "Accelerating P.A.C.E.² for Manufacturing & Automation Excellence," reflecting the focus on Productivity, Automation, Compliance, Efficiency, and EHS as key drivers of industry success. With 21 categories spanning both individual and organizational achievements, the awards celebrate the pioneering efforts that have revolutionized production, operations, and IT manufacturing within pharma.

What makes these awards stand out is their unwavering commitment to integrity and fairness. Judged by an elite panel of experts, the process is transparent and unbiased, ensuring that only the most deserving candidates receive recognition for their contributions.

In addition to celebrating excellence, the event also serves as a premium gathering for networking and collaboration among the industry’s elite. Leaders from across the sector will come together to discuss the future of pharma manufacturing, exchange ideas, and build partnerships.

For more information and to submit nominations, visit www.pmaeawards.com. Be part of this prestigious event and celebrate the future of pharma manufacturing!

2nd Annual Pharma Impurity Conclave 2024: Unveiling innovations & anticipating breakthroughs

The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety, efficacy, stability, and the quality of the drugs. To understand the challenges faced by scientists and analytical R&D experts to rid of residual solvents, degradants, or process related impurities, this conclave facilitates knowledge sharing, best practices dissemination, and regulatory updates to ensure practical understanding of those aspects and encourages the highest standards of product quality and patient safety. Ultimately, the 2nd Annual Pharma Impurity Conclave 2024 by Eminence Business Media, scheduled for September 12th – 13th at Hyderabad, serves as a critical platform for the industry professionals to address to those pressing needs for stringent impurity control in drug manufacturing.

Addressing Key Challenges in Pharmaceutical Impurities
Pharmaceutical impurities, whether they arise during the manufacturing process or through degradation over time, can pose significant risks to patient safety. The regulatory landscape governing these impurities is complex and continually evolving. 2nd Annual Pharma Impurities Conclave 2024 aims to provide attendees with the latest insights and practical strategies to navigate these challenges effectively.

A Stellar Line-Up of Expert Speakers
The event will feature a distinguished line-up of speakers from regulatory bodies and leading pharma companies. By bringing together scientists, regulatory experts, and industry leaders, the conclave is to foster collaboration and innovation in impurity analysis, detection, and control strategies.

Key Topics and Sessions
Participants can look forward to a comprehensive agenda that covers a wide range of topics related to pharmaceutical impurities:

Regulatory Updates: Detailed discussions on the latest guidelines from MHRA, FDA, EMA, and ICH, with a focus on permissible impurity levels and compliance requirements.

Analytical Techniques: Sessions on cutting-edge analytical methods for detecting and quantifying impurities, including advancements in mass spectrometry and chromatography.

Risk Assessment and Management: Expert-led discussions on risk assessment frameworks and best practices for managing impurities to ensure patient safety.

Case Studies: Real-world examples of impurity identification, mitigation strategies, and successful regulatory submissions.

Genotoxic Impurities: Special focus on the detection, evaluation, and control of genotoxic impurities, which can pose significant risks even at low levels.

Networking and Collaboration Opportunities
The conclave will also provide ample opportunities for networking and collaboration. Attendees can engage with peers, exchange ideas, and build professional relationships during dedicated networking sessions, panel discussions, and interactive workshops. The event aims to foster a collaborative environment where industry stakeholders can share knowledge and work together to advance the field of pharmaceutical quality control.

Join at the 2nd Annual Pharma Impurities Conclave 2024
Whether you are an Analytical R&D professional, QC expert, or researcher in the pharma, the 2nd Annual Pharma Impurities Conclave 2024 is an event you won't want to miss. Join us to stay at the forefront of developments in pharmaceutical impurities, gain valuable insights from industry leaders, and contribute to the ongoing effort to ensure the safety and efficacy of drug products.

For more information and to register, please visit www.pharmaimpurities.com

Cracking the Code of Cleaning Validation with 4th Annual Cleaning Validation 2024 : A Practical Approach

For pharma, maintaining stringent cleaning standards is non-negotiable. The stakes are high, and the margin for error is slim. Cross-contamination can compromise product quality, endanger patient safety, and lead to costly regulatory penalties. Despite countless discussions, cleaning validation continues to be a burning issue, frequently cited in FDA Form 483 observations.

Recognizing these challenges, Eminence Business Media is proud to announce the 4th Annual Cleaning Validation 2024 – A Practical Approach. This event promises to equip you with the knowledge and skills needed to tackle cleaning validation head-on, ensure compliance, and enhance product safety.

Why This Event Stands Out
Comprehensive Learning Experience: Over two action-packed days, delve into the core aspects of cleaning validation. From theoretical foundations to hands-on practical sessions, this workshop covers everything you need to know. Expect detailed discussions on effective cleaning practices, robust validation procedures, and meeting stringent regulatory requirements.

Practical Insights and Case Studies:
Theory meets practice at our workshop. Engage with real-life case studies and interactive simulations that mirror industry scenarios. Understand emerging strategies for cross-contamination control in multi-product facilities through true-to-life learning environments.

Expert-Led Sessions:
Learn from the best in the field. Our lineup of esteemed speakers brings their extensive experience and knowledge to the table. Participate in a fireside chat exploring the challenges of cleaning validation and strategies for navigating FDA 483 observations.

MACO Calculations Mastery:
The mini-masterclass on Maximum Allowable Carryover (MACO) calculations. Gain in-depth knowledge of calculation methodologies and practical applications, ensuring compliance and maintaining product safety. Test your understanding with an engaging quiz and hands-on exercises.

Interactive and Engaging Format:
We believe in making learning interactive and engaging. Participate in live Q&A sessions, group activities, and practical exercises designed to reinforce your understanding and address your specific queries. Enjoy networking breaks to connect with peers and industry leaders.

Continuous Learning and Support:
The learning doesn’t stop after the event. Benefit from a follow-up virtual session designed to address any questions that arise as you implement what you've learned. Additionally, enjoy six months of extended support, ensuring continuous learning and application in your professional life.

Who Should Attend:
This workshop is ideal for professionals overseeing cleaning validation programs, including executives, directors, managers, specialists, engineers, and other experts in engineering, cleaning validation, manufacturing science and technology, process monitoring and control, quality assurance/quality control, risk management, audit, documentation and analysis, and microbiology.

Don’t miss this opportunity to enhance your cleaning validation expertise and safeguard your processes against regulatory scrutiny. Join all at the Radisson Blu Mumbai International Airport for an event that promises to be insightful, practical, and transformative. Register now and take the next step towards mastering cleaning validation in the pharmaceutical industry.

The Nitrosamine Advanced Workshop 2024 to be held on May 9th - 10th, 2024 at Radisson Blu Mumbai

The presence of Nitrosamines, which are probable human carcinogens, has been an evolving challenge facing the pharmaceutical industry. Regulators became first aware of this impurity in mid – 2018, when NDMA was found in blood pressure medicine known as sartans. Ever since, the pharmaceutical industry has been working hard to mitigate the formation of Nitrosamines Impurities.

With the extensive research conducted by us, we have identified certain key challenges around nitrosamine formation, faced by the pharma manufacturers. We bring to you “Nitrosamine Advanced Workshop 2024” where we have experts from across the industry sharing their experience and expertise gained in this evolving concern.

To be held on May 9th – 10th, 2024 at Radisson Blu Mumbai International Airport, this workshop provides a comprehensive and in-depth exploration of nitrosamines, covering both updated regulatory guidelines and analytical understanding, and allowing participants to engage in practical discussions, case study solving sessions and hands-on learning experience. Join us to network with your industry peers and experts, discuss your challenges and get some practical solutions.

Why Attend:

1. Understand the ever-changing situation with Nitrosamines.
2. Discuss the evolving regulatory updates w.r.t Nitrosamines.
3. Dedicated time for Q & A to discuss and clarify your doubts.

Who Can Attend:

Designation:

•             Managing Director
•             Director
•             CXO’s
•             President
•             Sr. VP’s
•             VP’s
•             GM’s
•             Sr. Managers
•             Managers
•             Professionals from:

Department:

•             Analytical R & D
•             R & D
•             Quality Assurance
•             Quality Control
•             Manufacturing
•             Anyone handling Nitrosamine related Impurity profiling or monitoring.

Advance DoE Workshop 2024 to be held on May 9th & 10th, 2024 @ Hotel Radisson Blu Mumbai

For pharma and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Thus, the FDA mentions “Design of Experiments” (DoE) as an essential tool for achieving both regulatory compliance and faster time to market. To help you build quality into your process as outlined by ICH Q8, Q9, and Q10, Eminence Business Media is planning a two-day robust training program on “Advance DoE Workshop 2024” on May 9th – 10th. 2024 focuses on Towards Implementing Pharma QbD: Recent Paradigms and Techniques of Quintessential DoE.

Here, our trainers will help you learn concepts of Advanced Level Statistical Concepts required to Optimize Processes & achieve Product Robustness. The 2-day program will help you learn:

•             Plan, Design, Conduct, and Analyse experiments efficiently and effectively
•             Use response surface methods for system optimization as a follow-up to successful screening.
•             Use experimental design tools for computer experiments
•             Use software tools to create custom designs based on optimal design methodology

How will it help in your daily work?

•             More insight and knowledge of the design of experiments leads to improved process variation, performance aligned with planning, shorter development times, more reliability and reduced costs.

What’s Next?

•             Participants make better choices and schedules for experiments.
•             Participants can detect and discover interruptions early in the production process.
•             Participants can interpret test results in a more precise and complete fashion.

Who Attend?

Key Process Owners & core team members from the following departments of Pharma & Life Sciences

•             Research & Development
•             Formulation & Development
•             Process Excellence
•             Professional scientists, researchers
•             Improvement engineers and managers involved in quality engineering
•             S.Q.C / S.P.C - production, Laboratory and quality assurance and regulatory affairs